JP2018531907A5 - - Google Patents

Download PDF

Info

Publication number
JP2018531907A5
JP2018531907A5 JP2018511607A JP2018511607A JP2018531907A5 JP 2018531907 A5 JP2018531907 A5 JP 2018531907A5 JP 2018511607 A JP2018511607 A JP 2018511607A JP 2018511607 A JP2018511607 A JP 2018511607A JP 2018531907 A5 JP2018531907 A5 JP 2018531907A5
Authority
JP
Japan
Prior art keywords
compound
formula
reacting
stereoisomer
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018511607A
Other languages
English (en)
Japanese (ja)
Other versions
JP6736661B2 (ja
JP2018531907A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/049885 external-priority patent/WO2017040772A1/en
Publication of JP2018531907A publication Critical patent/JP2018531907A/ja
Publication of JP2018531907A5 publication Critical patent/JP2018531907A5/ja
Application granted granted Critical
Publication of JP6736661B2 publication Critical patent/JP6736661B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018511607A 2015-09-04 2016-09-01 治療化合物及び合成 Expired - Fee Related JP6736661B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562214727P 2015-09-04 2015-09-04
US201562214734P 2015-09-04 2015-09-04
US62/214,727 2015-09-04
US62/214,734 2015-09-04
PCT/US2016/049885 WO2017040772A1 (en) 2015-09-04 2016-09-01 Therapeutic compounds and synthesis

Publications (3)

Publication Number Publication Date
JP2018531907A JP2018531907A (ja) 2018-11-01
JP2018531907A5 true JP2018531907A5 (enExample) 2020-02-06
JP6736661B2 JP6736661B2 (ja) 2020-08-05

Family

ID=58188341

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2018511607A Expired - Fee Related JP6736661B2 (ja) 2015-09-04 2016-09-01 治療化合物及び合成
JP2018511670A Expired - Fee Related JP6639651B2 (ja) 2015-09-04 2016-09-01 疼痛のための治療化合物及びその合成
JP2018511605A Expired - Fee Related JP6736660B2 (ja) 2015-09-04 2016-09-01 疼痛のための治療化合物及びその合成
JP2018511601A Expired - Fee Related JP6736659B2 (ja) 2015-09-04 2016-09-01 疼痛のための治療化合物及びその合成
JP2018511626A Expired - Fee Related JP6868008B2 (ja) 2015-09-04 2016-09-01 疼痛のための治療化合物及びその合成

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2018511670A Expired - Fee Related JP6639651B2 (ja) 2015-09-04 2016-09-01 疼痛のための治療化合物及びその合成
JP2018511605A Expired - Fee Related JP6736660B2 (ja) 2015-09-04 2016-09-01 疼痛のための治療化合物及びその合成
JP2018511601A Expired - Fee Related JP6736659B2 (ja) 2015-09-04 2016-09-01 疼痛のための治療化合物及びその合成
JP2018511626A Expired - Fee Related JP6868008B2 (ja) 2015-09-04 2016-09-01 疼痛のための治療化合物及びその合成

Country Status (11)

Country Link
US (9) US10040795B2 (enExample)
EP (5) EP3344628B9 (enExample)
JP (5) JP6736661B2 (enExample)
CN (5) CN108290890B (enExample)
CA (5) CA2997545C (enExample)
DK (4) DK3344628T5 (enExample)
ES (4) ES2812233T3 (enExample)
IL (5) IL257740A (enExample)
MA (1) MA45011A (enExample)
TW (11) TWI713879B (enExample)
WO (5) WO2017040772A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6736661B2 (ja) * 2015-09-04 2020-08-05 ヤンセン ファーマシューティカ エヌ.ベー. 治療化合物及び合成

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1469781A (en) * 1974-06-10 1977-04-06 Boehringer Sohn Ingelheim Production of scopine
US4232026A (en) * 1978-07-20 1980-11-04 Merck & Co., Inc. Diazaditwistanes, and pharmaceutical compositions for treating pain in warm blooded animals containing them
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4532244A (en) * 1984-09-06 1985-07-30 Innes Margaret N Method of treating migraine headaches
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
JP2514137B2 (ja) * 1990-07-23 1996-07-10 フアイザー・インコーポレイテツド キヌクリジン誘導体
DE553264T1 (de) 1990-10-05 1994-04-28 Wayne M Barnes Thermostabile dna polymerase.
US6432976B1 (en) * 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
WO2004106333A1 (en) * 2003-05-28 2004-12-09 Theravance, Inc. Azabicycloalkane compounds as muscarinic receptor antagonists
ES2356356T3 (es) * 2003-10-15 2011-04-07 Targacept, Inc. Compuestos azabicíclicos para aliviar el dolor y tratar los trastornos del sistema nervioso central.
ATE482959T1 (de) * 2005-08-22 2010-10-15 Targacept Inc Heteroarylsubstituierte diazatricycloalkane, verfahren zu deren herstellung und deren anwendung
US8735411B2 (en) * 2006-10-02 2014-05-27 Abbvie Inc. Macrocyclic benzofused pyrimidine derivatives
WO2008104955A1 (en) * 2007-02-28 2008-09-04 Ranbaxy Laboratories Limited Azoniatricyclo [3.3.1.0] nonane derivatives as muscarinic receptor antagonists
TW200840569A (en) * 2007-03-13 2008-10-16 Targacept Inc Sub-type selective amides of diazabicycloalkanes
WO2009124755A1 (en) * 2008-04-08 2009-10-15 European Molecular Biology Laboratory (Embl) Compounds with novel medical uses and method of identifying such compounds
CN101768158B (zh) * 2010-01-04 2013-05-29 南昌弘益科技有限公司 噻托溴铵无水物及其制备方法
CN102579458A (zh) * 2012-03-08 2012-07-18 冀中能源峰峰集团有限公司总医院 缓解静点药物所致疼痛和防治静脉炎的药品配方
JP6102122B2 (ja) * 2012-08-24 2017-03-29 ソニー株式会社 画像処理装置および方法、並びにプログラム
EP2897948B1 (en) * 2012-09-18 2016-08-31 Heptares Therapeutics Limited Bicyclic aza compounds as muscarinic m1 receptor agonists
TW201444849A (zh) * 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
JO3509B1 (ar) * 2013-03-14 2020-07-05 Janssen Pharmaceutica Nv معدلات p2x7
KR20160115503A (ko) * 2015-03-27 2016-10-06 차의과학대학교 산학협력단 만성 골수성 백혈병 암 줄기세포의 성장 또는 증식 억제용 조성물 및 이의 스크리닝 방법
GB201505654D0 (en) * 2015-04-01 2015-05-13 Nordic Bioscience As Immunoassay for collagen type VI sequence
GB201505701D0 (en) * 2015-04-02 2015-05-20 Byotrol Plc Anti-microbial composition
JP6736661B2 (ja) * 2015-09-04 2020-08-05 ヤンセン ファーマシューティカ エヌ.ベー. 治療化合物及び合成

Similar Documents

Publication Publication Date Title
KR101934096B1 (ko) 이델라리십의 제조방법
JP2013505259A5 (enExample)
JP6394690B2 (ja) 1,1−ジ置換ヒドラジン化合物の製造方法
JP2015523337A5 (enExample)
JP2018531907A5 (enExample)
JP6815932B2 (ja) N−カルバメート保護カルボキシ無水物の製造方法
JP2021504505A5 (enExample)
JP2010235601A5 (enExample)
JP6548214B2 (ja) アミノサリチルアルジミン配位子を金属に配位させた触媒及びこれを用いたヨード環化体の製造方法
CN102924548B (zh) 卡培他滨的合成方法
CN103694162B (zh) (1s,2r)-1-苯基2-(酞酰亚胺)甲基-n,n-二乙基-环丙甲酰胺的制备方法
EP1363878B1 (en) Process for preparing sulfamoyl-substituted phenethylamine derivatives
US8729138B2 (en) Mixture of polyfluoroalkylsulfonamido alkyl amines
JP2017513885A5 (enExample)
US8779196B2 (en) Polyfluoroalkylsulfonamido alkyl halide intermediate
CN103421037B (zh) 1-乙氧羰基-5-甲基-(3r)-叔丁基二甲硅氧基戊二酸酯的合成工艺
CN106674198A (zh) 一种雷贝拉唑关键中间体硫醚物的制备方法
JP2017514846A5 (enExample)
JPH1192453A (ja) ピリジルメチルイソチオシアネートの製造法
KR101453413B1 (ko) 알파-카르볼린 유도체의 제조방법
JP2012513391A5 (enExample)
JP4239473B2 (ja) ピリドン化合物の製造法およびその中間体
JP6371077B2 (ja) ジフルオロメチル基含有化合物及びその用途
JP2013129616A (ja) 臭素化剤及びその利用
JP4853987B2 (ja) α−置換化合物の製造方法